We are live on
!
Find out more
JAG
Journey Advisory Group Portfolio holdings
AUM
$1.31B
1-Year Est. Return
24.92%
This Fund
S&P 500
This Quarter
Est. Return
-1.18%
1 Year Est. Return
+24.92%
3 Year Est. Return
+66.16%
5 Year Est. Return
+83.95%
10 Year Est. Return
–
AUM
$835M
AUM Growth
-$77.2K
(-0.01%)
Cap. Flow
-$12.3M
Cap. Flow
% of AUM
-1.48%
Top 10 Holdings %
Top 10 Hldgs %
34.57%
Holding
228
New
2
Increased
–
Reduced
7
Closed
2
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$6.58M |
| 2 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$4.54M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$3.36M |
| 4 |
Cencora
COR
|
+$543K |
| 5 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$494K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.37% |
| 2 | Healthcare | 7.62% |
| 3 | Consumer Staples | 6.77% |
| 4 | Industrials | 6.17% |
| 5 | Financials | 5.97% |
Similar funds
PCM
PFBT
SP
HCS
SPC
GPCM
MCM
CC
Journey Advisory Group's Q4 2024 Portfolio in Review
As of Q4 2024, Journey Advisory Group held 228 positions worth $835M, down 0.01% from $835M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Trading was light in Q4 2024: portfolio turnover was 1.8%. Journey Advisory Group opened 2 new positions and exited 2, leaving the 228-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Staples.
- Journey Advisory Group's biggest Q4 2024 reduction was Schwab Short-Term US Treasury ETF, cutting an estimated $6.58M.
- Journey Advisory Group fully exited Invesco QQQ Trust in Q4 2024, selling an estimated $3.36M.
- Journey Advisory Group's ten largest holdings make up 35% of its $835M portfolio in Q4 2024.
- Journey Advisory Group opened 2 new positions and closed 2 in Q4 2024.
- Journey Advisory Group's portfolio value fell 0.01% quarter-over-quarter to $835M.
Based on Journey Advisory Group's 13F filing for Q4 2024, filed 4 Feb 2025.